
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
NSI-189 is an experimental neuroplasticity compound that promotes hippocampal neurogenesis through BDNF pathway activation. It demonstrates potential for enhancing memory formation and mood regulation by stimulating the growth of new brain cells.

Reported Benefits (Provisional)
Origin & History

NSI-189 is a synthetic compound developed by Neuralstem, Inc., designed to stimulate neurogenesis. It is synthesized through a series of chemical reactions to create a novel molecule.
Research Narrative (Provisional)
NSI-189 has been studied in early-phase clinical trials, showing promise in enhancing cognitive function and treating depression, though more research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Synthetic compound with no caloric or macronutrient content. - Stimulates neurogenesis in the hippocampus. - Modulates brain-derived neurotrophic factor (BDNF) pathways.
Reported Mechanism (Provisional)
NSI-189 activates brain-derived neurotrophic factor (BDNF) signaling pathways, specifically targeting the hippocampus to stimulate neurogenesis. The compound modulates the hypothalamic-pituitary-adrenal axis, reducing cortisol production while enhancing synaptic plasticity. It also influences CREB-mediated gene transcription, promoting the survival and integration of newly formed neurons.
Clinical Narrative (Provisional)
NSI-189 has completed Phase I and Phase II clinical trials for major depressive disorder, with studies involving 220 participants showing modest improvements in cognitive assessments. A 12-week randomized controlled trial demonstrated 35% improvement in memory tasks compared to placebo. However, the compound failed to meet primary endpoints for depression treatment in Phase II trials. Current evidence remains limited, with most cognitive benefits observed in small-scale studies requiring larger replication trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







